其他產(chǎn)品及廠家

PDE4-IN-14；化合物 PDE4-IN-14PDE4-IN-14
pde4-in-14 (compound 1) serves as an inhibitor of phosphodiesterase 4 (pde4), applicable in research concerning diseases associated with pde4, including inflammatory and immune disorders, cancer, and metabolic diseases [1].
更新時(shí)間:2025-09-05
HCV-IN-43；化合物 HCV-IN-43HCV-IN-43
hcv-in-43 (compound 2), an hcv ns5b protein inhibitor, efficiently inhibits hcv virus replication and is utilized in the study of hcv infection [1].
更新時(shí)間:2025-09-05
HCV-IN-44；化合物 HCV-IN-44HCV-IN-44
hcv-in-44 (compound 28) is an inhibitor of the hcv ns5b protein, efficacious in suppressing hcv virus replication and useful for researching hcv infection [1].
更新時(shí)間:2025-09-05
PI3Kδ-IN-13；化合物 PI3Kδ-IN-13PI3Kδ-IN-13
pi3kδ-in-13 (compound 89), with an ic50 value of 2.6 nm, is an inhibitor of pi3kδ, applicable for researching diseases involving cell proliferation, including cancer, infection, inflammation, and autoimmune disorders [1].
更新時(shí)間:2025-09-05
DprE1-IN-8；化合物 DprE1-IN-8DprE1-IN-8
dpre1-in-8 is a potent inhibitor of dpre1, exhibiting an ic50 of less than 0.75 μm. it has demonstrated significant activity against mtb h37rv, with an ic50 value of 6 nm, making it applicable in tuberculosis research [1].
更新時(shí)間:2025-09-05
Tubulin polymerization-IN-46；化合物 Tubulin polymerization-IN-46Tubulin polymerization-IN-46
tubulin polymerization-in-46 (compound 9q) is a microtubule/tubulin inhibitor that impedes tubulin polymerization, induces apoptosis, and arrests mcf-7 breast cancer cells in the g2/m phase, exhibiting potent anti-proliferative activity with an ic50 of 10 nm [1].
更新時(shí)間:2025-09-05
2,4-Dihydroxypyridine；2,4-二羥基吡啶2,4-Dihydroxypyridine
2,4-dihydroxypyridine is a pyridine derivative that acts as a chelating agent binding to metal ions and forming complexes. it is used as a reagent for determining the concentration of various ions, such as calcium, magnesium and phosphate. it is also used to measure the rate of enzyme-catalyzed reactions. it is also used for the detection and quantification of proteins, carbohydrates and other biomolecules.
更新時(shí)間:2025-09-05
CDK9-IN-25；化合物 CDK9-IN-25CDK9-IN-25
cdk9-in-25 (compound 4a), an imidazopyrazine derivative, functions as a cdk9 inhibitor with an ic50 of 0.24 μm. it also exhibits affinity for the main protease of covid-19 and demonstrates antiviral activity against human coronavirus 229e, with an ic50 of 63.28 μm [1].
更新時(shí)間:2025-09-05
CDK9-IN-26；化合物 CDK9-IN-26CDK9-IN-26
cdk9-in-26, also known as compound 1, is a potent inhibitor of cyclin-dependent kinase 9 (cdk9) with an ic50 value of 0.18 μm.[1]
更新時(shí)間:2025-09-05
Antileishmanial agent-21；化合物 Antileishmanial agent-21Antileishmanial agent-21
antileishmanial agent-21 (compound 4e) functions as an inhibitor of leishmania pteridine reductase 1 (lm-ptr1), employing an anti-folate mechanism. its antileishmanial effects can be negated by folic acid and leucovorin. additionally, it demonstrates inhibitory activity against the chloroquine-resistant plasmodium falciparum strain rkl9, with an ic50 ranging from 0.0198 to 0.096 μm [1].
更新時(shí)間:2025-09-05
LYP-IN-4；化合物 LYP-IN-4LYP-IN-4
lyp-in-4 (compound d14), a reversible and selective lymphotyrosine phosphatase (lyp) inhibitor (ki=1.34 μm, ic50=3.52μm), regulates tcr signaling, increases pd-1/pd-l1 expression, and strengthens anti-tumor immunity. it also stimulates t cell activation, impedes m2 macrophage polarization, and suppresses tumor progression in mc38 isogenic mouse models.
更新時(shí)間:2025-09-05
PKM2-IN-4；化合物 PKM2-IN-4PKM2-IN-4
compound 5c, referred to as pkm2-in-4, is a selective pkm2 inhibitor (ic50 = 0.35 ?m) that modulates pyruvate-dependent respiration and promotes mitochondrial h2o2 production rate and electron transport system coupling [1].
更新時(shí)間:2025-09-05
CIAC001；化合物 CIAC001CIAC001
ciac001, a pyruvate kinase pkm2 inhibitor, exhibits anti-neuroinflammatory properties. it effectively suppresses lps-induced production of proinflammatory nitric oxide (no) and provides protection to immunologically active bv-2 cells with an ic50 value of 2.5 μm. additionally, ciac001 demonstrates anti-neuroinflammation effects in mouse models and attenuates chronic morphine-induced addiction [1].
更新時(shí)間:2025-09-05
Lepadin E；化合物 Lepadin ELepadin E
lepadin e, a notably cytotoxic compound, effectively stimulates ferroptosis via the canonical p53-slc7a11-gpx4 pathway. by elevating p53 and repressing slc7a11 and gpx4 expression, it heightens ros and lipid peroxidation while also augmenting acsl4 expression, culminating in cell death. this compound exhibits a considerable antitumor effect [1].
更新時(shí)間:2025-09-05
Lepadin H；化合物 Lepadin HLepadin H
lepadin h, a marine alkaloid and ferroptosis inducer, exhibits significant cytotoxicity by promoting p53 expression, escalating ros production, and enhancing lipid peroxidation. it simultaneously decreases slc7a11 and gpx4 levels while upregulating acsl4 expression, thereby inducing ferroptosis via the p53-slc7a11-gpx4 pathway [1].
更新時(shí)間:2025-09-05
Isomalt；異麥芽酮糖醇Palatinitol|||Palatinit；異麥芽酮糖醇|||Palatinitol|||Palatinit
isomalt (palatinitol) is a mixture of 1,6-mannitol glucopyranoside and 1,6-sorbitol glucopyranoside
更新時(shí)間:2025-09-05
ZNL-05-044；化合物 ZNL-05-044ZNL-05-044
znl-05-044, a cdk11 inhibitor, exhibits ic50 values of 0.23 μm for cdk11a and 0.27 μm for cdk11b, as determined by nanobret assay. it induces g2/m cell cycle arrest and disrupts rna splicing [1].
更新時(shí)間:2025-09-05
IV-275；化合物 IV-275IV-275
iv-275 is a dual inhibitor targeting the bromodomains of both brg1 and brm. this compound not only augments dna damage when combined with temozolomide and bleomycin but also suppresses the invasiveness of gbm cells. furthermore, iv-275 amplifies temozolomide-induced cell death and its apoptosis-inducing activity [1].
更新時(shí)間:2025-09-05
PD-1/PD-L1-IN-33；化合物 PD-1/PD-L1-IN-33PD-1/PD-L1-IN-33
pd-1/pd-l1-in-33 (compound n11), a pd-1/pd-l1 inhibitor, effectively impedes the interaction between pd-1 and pd-l1 with an ic50 of 6.3 nm. by doing so, it enhances t-cell proliferation, activation, and infiltration within tumor environments, exhibiting immunomodulatory and anticancer properties [1].
更新時(shí)間:2025-09-05
Antidiabetic agent 2；化合物 Antidiabetic agent 2Antidiabetic agent 2
compound 56 (antidiabetic agent 2) is a glucose-uptake promoter that inhibits dpp-4, ptp-1b, α-amylase, and α-glucosidase, with ic50 values of 0.036, 0.042, 0.241, and 0.185 μm, respectively. this agent effectively decreases blood glucose levels [1].
更新時(shí)間:2025-09-05
Tubulin polymerization-IN-48；化合物 Tubulin polymerization-IN-48Tubulin polymerization-IN-48
tubulin polymerization-in-48 (compound 4k) is an inhibitor of tubulin polymerization, moderately disrupting the microtubule network. it impedes the proliferation of neuroblastoma cancer cells, exhibiting ic50 values of 79 nm and 165 nm for the chp-134 and kelly cell lines, respectively [1].
更新時(shí)間:2025-09-05
Anticancer agent 153；化合物 Anticancer agent 153Anticancer agent 153
anticancer agent 153 (compound 3) promotes apoptosis through the generation of reactive oxygen species (ros) and elevates the loss of mitochondrial membrane potential (mmp), effectively inhibiting cancer cell proliferation [1].
更新時(shí)間:2025-09-05
VEGFR/PARP-IN-1；化合物 VEGFR/PARP-IN-1VEGFR/PARP-IN-1
vegfr/parp-in-1 (compound 14b) is a dual inhibitor of vegfr and parp with ic50 values of 191 nm and 60.9 nm, respectively. it impairs dna damage repair pathways, promotes apoptosis, and halts cells in the g2/m phase. this compound demonstrates considerable antiproliferative activity against brca wild-type breast cancer cells, with ic50 values of 4.1 μm for mda-mb-231 cells and 3.5 μm for mcf-7 cells, indicating its potential as an antitumor and anti-metastasis agent [1].
更新時(shí)間:2025-09-05
CDK2-IN-19；化合物 CDK2-IN-19CDK2-IN-19
cdk2-in-19 (compound 32) is a selective, orally active inhibitor of cdk2 (k i: 0.18 nm) that exhibits anticancer activity in mice with ovcar3 tumors [1].
更新時(shí)間:2025-09-05
CB1R/AMPK modulator 1；化合物 CB1R/AMPK modulator 1CB1R/AMPK modulator 1
compound 38-s is an orally active cb1r/ampk modulator with a k i of 0.81 nm and an ic50 of 3.9 nm for cb1r. this compound activates ampk and has been shown to decrease food intake and body weight, in addition to enhancing glucose tolerance and insulin sensitivity [1].
更新時(shí)間:2025-09-05
HBV-IN-40；化合物 HBV-IN-40HBV-IN-40
hbv-in-40 (compound 11826096), with an ic50 of 0.7 ?m, serves as a potent hbv inhibitor and exhibits antiviral activity [1].
更新時(shí)間:2025-09-05
EGFR-IN-83；化合物 EGFR-IN-83EGFR-IN-83
egfr-in-83 (compound 9), an egfr inhibitor with an ic50 of 2.53 nm, exhibits antiproliferative effects on mcf-7 and mda-mb-231 cell lines, with respective ic50 values of 2.50 μm and 1.96 μm. furthermore, egfr-in-83 is capable of inducing cell apoptosis [1].
更新時(shí)間:2025-09-05
Urease-IN-7；化合物 Urease-IN-7Urease-IN-7
urease-in-7 (compound 5k) acts as a competitive inhibitor of the enzyme urease, exhibiting an ic50 value of 3.33 μm and a k_i of 3.62 μm. this compound has potential applications in the study of peptic and gastric ulcers [1].
更新時(shí)間:2025-09-05
VISTA-IN-2；化合物 VISTA-IN-2VISTA-IN-2
vista-in-2 (compound 1) is a v-domain ig suppressor of t-cell activation (vista) inhibitor that promotes the degradation of vista in cells via autophagy, reverses vista-related immunosuppression, and fortifies the antitumor responses of immune cells. additionally, this compound stimulates antitumor immunity and suppresses tumor growth in a ct26 mouse model [1].
更新時(shí)間:2025-09-05
CRM1-IN-1；化合物 CRM1-IN-1CRM1-IN-1
crm1-in-1 (compound kl1), a noncovalent inhibitor of crm1, promotes nuclear degradation of crm1 with an ic50 of 0.27 μm, inhibits crm1-mediated nuclear export, suppresses cell proliferation, and induces apoptosis in colorectal cancer cells [1].
更新時(shí)間:2025-09-05
CRM1-IN-2；化合物 CRM1-IN-2CRM1-IN-2
crm1-in-2 (compound kl2) is a noncovalent inhibitor that targets crm1, localizing it to the nuclear periphery, depleting its nuclear presence, and inhibiting its nuclear export function. it demonstrates the capability to inhibit the growth of colorectal cancer cells and induce apoptosis [1].
更新時(shí)間:2025-09-05
Urease-IN-8；化合物 Urease-IN-8Urease-IN-8
urease-in-8 (compound 5e) functions as a competitive inhibitor of urease, with an ic50 value of 3.51 μm and a ki of 3.11 μm. it is applicable for research pertaining to peptic and gastric ulcers [1].
更新時(shí)間:2025-09-05
MeOIstPyrd；化合物 MeOIstPyrdMeOIstPyrd
meoistpyrd is an anti-skin cancer agent that inhibits cell proliferation, migration, and spheroid formation through activation of the mitochondrial intrinsic apoptotic pathway. it induces dna damage, activates p53, prolongs its half-life, and stabilizes p53 via ser15 phosphorylation. additionally, meoistpyrd interfaces with mdm2 within the p53 sub-pocket, preventing the p53-mdm2 interaction [1].
更新時(shí)間:2025-09-05
PI3Kδ-IN-14；化合物 PI3Kδ-IN-14PI3Kδ-IN-14
pi3kδ-in-14 (compound (s)-29), a selective pi3kδ inhibitor with an ic50 of 0.8 nm and a kd of 84.8 nm, targets the atp-binding site within the kinase domain of pi3kδ. this compound exhibits anti-inflammatory properties by impeding the pi3k/akt pathway and is noted for alleviating acute lung injury (ali) [1].
更新時(shí)間:2025-09-05
SARS-CoV-2 3CLpro-IN-16；SARS-CoV-2 3CLpro 抑制劑16SARS-CoV-2 3CLpro-IN-16
sars-cov-2 3clpro-in-16 is a covalent sars-cov-2 3clpro inhibitor that inhibits 3clpro activity and achieves its inhibitory effect by forming a covalent bond with cys145.
更新時(shí)間:2025-09-05
3-O-Ethyl-L-ascorbic acid；3-O-乙基抗壞血酸醚3-O-Ethyl-L-ascorbic acid
3-o-ethyl-l-ascorbic acid is a cosmetic tyrosinase inhibitor with whitening ability and is a stabilized vitamin c derivative. it also has antioxidant properties.
更新時(shí)間:2025-09-05
SARS-CoV-2 3CLpro-IN-17；化合物 SARS-CoV-2 3CLpro-IN-17SARS-CoV-2 3CLpro-IN-17
compound 3h, also known as sars-cov-2 3clpro-in-17, is a selective inhibitor of the sars-cov-2 3cl protease, demonstrating an ic50 of 0.322 μm [1].
更新時(shí)間:2025-09-05
SARS-CoV-2 3CLpro-IN-18；化合物 SARS-CoV-2 3CLpro-IN-18SARS-CoV-2 3CLpro-IN-18
sars-cov-2 3clpro-in-18 (compound 3c) is a covalent inhibitor of sars-cov-2 3clpro with an ic50 of 0.478 μm. it demonstrates inhibition of sars-cov-2 in vero e6 cells, with an ec50 of 2.499 μm, and exhibits low cytotoxicity (cc50 > 200 μm) [1].
更新時(shí)間:2025-09-05
E07 aptamer；化合物 E07 aptamerE07 aptamer
sars-cov-2 nsp14-in-4 (compound 12q) is a selective inhibitor of the sars-cov-2 nsp14 methyltransferase with an ic50 of 19 ± 2.5 nm. lacking a zwitterionic character, it can penetrate cells and is useful in research on covid-19 and its etiological agent, sars-cov-2 [1].
更新時(shí)間:2025-09-05
RUNX-IN-2；化合物 RUNX-IN-2RUNX-IN-2
runx-in-2 (compound conjugate 3) covalently attaches to runx-binding sequences, preventing runx proteins from associating with their targets, thereby inhibiting cancer cell proliferation and inducing p53-dependent apoptosis. furthermore, runx-in-2 suppresses tumor development in panc-1 xenograft mice and demonstrates notable alkylation efficiency and specificity [1].
更新時(shí)間:2025-09-05
WLB-89462；化合物 WLB-89462WLB-89462
wlb-89462 (compound 20c) is a selective σ2 receptor ligand with a k i of 13 nm, exhibiting neuroprotective properties and the ability to ameliorate aβ peptide-induced short-term memory impairment in rats. it possesses a favorable admet profile characterized by good solubility, absence of cyp inhibition, robust metabolic stability, high permeability, effective brain penetration, and substantial oral exposure in rodent models [1].
更新時(shí)間:2025-09-05
YCH1899；化合物 YCH1899YCH1899
ych1899, an orally active parp inhibitor, demonstrates potent inhibition of parp1/2 with an ic50 of less than 0.001 nm. it shows marked antiproliferative efficacy against olaparib-resistant (capan-1/op) and talazoparib-resistant (capan-1/tp) cells with ic50 values of 0.89 nm and 1.13 nm, respectively. moreover, ych1899 possesses favorable pharmacokinetic attributes in rats [1].
更新時(shí)間:2025-09-05
PIK5-12d；化合物 PIK5-12dPIK5-12d
pik5-12d, a potent protac pikfyve degrader (dc50: 1.48 nm), effectively induces cytoplasmic vacuolization and inhibits autophagic flux in various prostate cancer cell lines, concurrently halting their proliferation. this compound has demonstrated significant anti-tumor activity [1].
更新時(shí)間:2025-09-05
FD2157；化合物 FD2157FD2157
fd2157, a photosensitive pi3k inhibitor, exhibits inhibitory ic50 values of 43 nm for pi3kα, 83 nm for pi3kβ, 84 nm for pi3kγ, and 14 nm for pi3kδ. upon exposure to 365 nm uv light, fd2157 effectively inhibits cancer cell proliferation and induces apoptosis [1].
更新時(shí)間:2025-09-05
Methyl behenate山楂酸甲酯山楂酸甲酯|||山崳酸甲酯
methyl behenate is a natural compound, is an ester form of docosanoic acid .
更新時(shí)間:2025-09-05
Anti-inflammatory agent 56；化合物 Anti-inflammatory agent 56Anti-inflammatory agent 56
anti-inflammatory agent 56 (compound 9), a selective cox-2 inhibitor with an ic50 of 0.54 μm, exhibits anti-oxidant and anti-inflammatory properties by inhibiting oxidative stress-induced cell death and neuroinflammation through the suppression of keap1, cox-2, and inos. it also demonstrates low acute toxicity in mice with an ld50 of 1000 mg/kg [1].
更新時(shí)間:2025-09-05
nf-κb-in-11 (compound 3i) is an inhibitor of nf-κb, effectively blocking tnf-α-induced nf-κb pathway activation and the nuclear translocation of nf-κb. it also reduces the expression levels of phospho-ikk, iκbα, and nf-κb p65. demonstrating anti-inflammatory properties, nf-κb-in-11 mitigates dextran sulfate sodium-induced colitis in mice and exhibits a maximum tolerated dose (mtd) exceeding 1852 mg/kg in acute toxicity assays when administered orally (p.o.) [1].
更新時(shí)間:2025-09-05
DUB-IN-7；化合物 DUB-IN-7DUB-IN-7
dub-in-7 (compound 43), a deubiquitinating enzyme (dub) inhibitor, has utility in researching diseases driven by aberrant jak2 activity, including leukemia [1].
更新時(shí)間:2025-09-05
LUNA18；化合物 LUNA18LUNA18
luna18 is an orally active inhibitor targeting kras, exhibiting potent activity with an ic50 value of less than 2 nm against the kras g12d-sos mutation. it is utilized in cancer research [1].
更新時(shí)間:2025-09-05
HDAC-IN-64；化合物 HDAC-IN-64HDAC-IN-64
hdac-in-64 (compound 13), an hdac inhibitor, demonstrates potent inhibition of hdac4/5/6/7/9 with ic50 values of 24, 45, 85, 31, and 37 nm, respectively. it exhibits anti-proliferative and anti-migration effects on prostate cancer (pca) cells, specifically inhibiting the growth of lncap and rwpe-1 cells with gi50 values of 0.32 and 1.1 μm, respectively [1].
更新時(shí)間:2025-09-05

最新產(chǎn)品

熱門儀器： 液相色譜儀 氣相色譜儀 原子熒光光譜儀 可見(jiàn)分光光度計(jì) 液質(zhì)聯(lián)用儀 壓力試驗(yàn)機(jī) 酸度計(jì)（PH計(jì)） 離心機(jī) 高速離心機(jī) 冷凍離心機(jī) 生物顯微鏡 金相顯微鏡 標(biāo)準(zhǔn)物質(zhì) 生物試劑